These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28711713)

  • 61. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
    Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
    FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
    Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
    Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
    Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
    Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lysophosphatidylcholine increases the neurotoxicity of Alzheimer's amyloid β1-42 peptide: role of oligomer formation.
    Sheikh AM; Michikawa M; Kim SU; Nagai A
    Neuroscience; 2015 Apr; 292():159-69. PubMed ID: 25727637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower Aβ₄₂ production.
    Takai T; Koike T; Honda E; Kajita Y; Nakamura M; Morimoto S; Hoashi Y; Kamata M; Watanabe T; Igari T; Terauchi J
    Bioorg Med Chem; 2015 May; 23(9):1923-34. PubMed ID: 25842363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.
    Hara H; Ono F; Nakamura S; Matsumoto SE; Jin H; Hattori N; Tabira T
    J Alzheimers Dis; 2016 Oct; 54(3):1047-1059. PubMed ID: 27567868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers.
    Huang D; Zimmerman MI; Martin PK; Nix AJ; Rosenberry TL; Paravastu AK
    J Mol Biol; 2015 Jul; 427(13):2319-28. PubMed ID: 25889972
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of Vitamin D on amyloid precursor protein processing and amyloid-β peptide degradation in Alzheimer's disease.
    Grimm MO; Lehmann J; Mett J; Zimmer VC; Grösgen S; Stahlmann CP; Hundsdörfer B; Haupenthal VJ; Rothhaar TL; Herr C; Bals R; Grimm HS; Hartmann T
    Neurodegener Dis; 2014; 13(2-3):75-81. PubMed ID: 24192346
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
    Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
    Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.
    Caballero AB; Terol-Ordaz L; Espargaró A; Vázquez G; Nicolás E; Sabaté R; Gamez P
    Chemistry; 2016 May; 22(21):7268-80. PubMed ID: 27071336
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilities.
    Lohman RJ; Nielsen DS; Kok WM; Hoang HN; Hill TA; Fairlie DP
    Chem Commun (Camb); 2019 Nov; 55(89):13362-13365. PubMed ID: 31631195
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Design, Synthesis and Preliminary Pharmacokinetic Evaluation of d3-Poziotinib Hydrochloride.
    Ma S; Wang L; Ouyang B; Bai X; Ji Q; Yao L
    Biol Pharm Bull; 2019; 42(6):873-876. PubMed ID: 31155586
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease.
    Kutzsche J; Schemmert S; Tusche M; Neddens J; Rabl R; Jürgens D; Brener O; Willuweit A; Hutter-Paier B; Willbold D
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28994710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug candidates in clinical trials for Alzheimer's disease.
    Hung SY; Fu WM
    J Biomed Sci; 2017 Jul; 24(1):47. PubMed ID: 28720101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amyloid beta: structure, biology and structure-based therapeutic development.
    Chen GF; Xu TH; Yan Y; Zhou YR; Jiang Y; Melcher K; Xu HE
    Acta Pharmacol Sin; 2017 Sep; 38(9):1205-1235. PubMed ID: 28713158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.